Banner

Significance of BRAF and Nrf2 in evaluation of Serous Ovarian tumors

Egyptian Journal of Pathology • 2020
Back
Publication Information
Authors Amira E.Soliman1 (Msc) , Ghada A. Abd El-Fattah1 (MD),Taghreed A. Abd Elaziz1 (MD), Magda H. Nasreldin2 (MD) , Ahmed M. Khalil 3(MD MRCOG), Hala A. Agina1 (MD)
Keywords Nrf2, BRAF, Immunohistochemistry, Serous ovarian tumors.
Journal Egyptian Journal of Pathology
Publisher Wolters Kluwer
Volume 40
Issue 1
Pages 28-36
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Abstract
Background: Ovarian carcinoma is the second leading cause of cancer-related deaths among females. Many treatment strategies have been developed; however, the prognosis is still poor. This study aims to evaluate the immunohistochemical expression of BRAF and Nrf2 in serous ovarian tumors and to correlate their expression with clinicopathological features of the cases.
Material and methods: This uncontrolled retrospective study was performed on 50 cases; benign (10), borderline (12) and malignant serous ovarian neoplasm (28). The malignant serous tumors included 9 low grade cases and 19 high grade cases. The immunohistochemical expression of Nrf2 and BRAF was correlated with clinicopathological features of prognostic importance.
Results: The mean of BRAF expression is increased in borderline but it is almost equal for low grade and high- grade carcinoma which was statistically significant (P value